Opportunistic co-screening for HCV and COVID-19-related services: A creative response with a need for thoughtful reflection

doi:10.1111/liv.15243

Editorial

. 2022 May;42(5):960-962.

doi: 10.1111/liv.15243.

Opportunistic co-screening for HCV and COVID-19-related services: A creative response with a need for thoughtful reflection

Loreta A Kondili¹, Lucia Craxì², Massimo Andreoni³, Francesco S Mennini⁴, Homie Razavi⁵

Affiliations

¹ Center for Global Health, Istituto Superiore di Sanità, Rome, Italy.
² Department of Biomedicine, Neuroscience and Advanced Diagnostics (Bi.N.D.), University of Palermo, Palermo, Italy.
³ Infectious Disease Unit, Department of System Medicine, Tor Vergata University and Hospital, Rome, Italy.
⁴ Economic Evaluation and HTA (EEHTA), CEIS, Faculty of Economics, University of Rome "Tor Vergata" and Institute of Leadership and Management in Health, Kingston Business School, Kingston University, London, UK.
⁵ Center for Disease Analysis Foundation, Lafayette, Colorado, USA.

PMID: 35447008
PMCID: PMC9115188
DOI: 10.1111/liv.15243

Editorial

Opportunistic co-screening for HCV and COVID-19-related services: A creative response with a need for thoughtful reflection

Loreta A Kondili et al. Liver Int. 2022 May.

. 2022 May;42(5):960-962.

doi: 10.1111/liv.15243.

Authors

Loreta A Kondili¹, Lucia Craxì², Massimo Andreoni³, Francesco S Mennini⁴, Homie Razavi⁵

Affiliations

¹ Center for Global Health, Istituto Superiore di Sanità, Rome, Italy.
² Department of Biomedicine, Neuroscience and Advanced Diagnostics (Bi.N.D.), University of Palermo, Palermo, Italy.
³ Infectious Disease Unit, Department of System Medicine, Tor Vergata University and Hospital, Rome, Italy.
⁴ Economic Evaluation and HTA (EEHTA), CEIS, Faculty of Economics, University of Rome "Tor Vergata" and Institute of Leadership and Management in Health, Kingston Business School, Kingston University, London, UK.
⁵ Center for Disease Analysis Foundation, Lafayette, Colorado, USA.

PMID: 35447008
PMCID: PMC9115188
DOI: 10.1111/liv.15243

No abstract available

PubMed Disclaimer

Conflict of interest statement

All authors declare no conflict of interest related to the subject matter of this paper.

Figures

**FIGURE 1**
HCV screening for disease control and infection burden reduction

See this image and copyright information in PMC

Comment in

HCV point of care screening in people tested for SARS-CoV-2 in a social-housing neighbourhood of Milan, Italy.
Beltrami M, Pagani G, Conti F, Pezzati L, Casalini G, Rondanin R, Prina A, Zagari A, Galli M, Giacomelli A. Beltrami M, et al. Liver Int. 2023 Jan;43(1):251-255. doi: 10.1111/liv.15375. Epub 2022 Aug 8. Liver Int. 2023. PMID: 35869660 Free PMC article. No abstract available.

Cited by

Combined COVID-19 vaccination and hepatitis C virus screening intervention in marginalised populations in Spain.
Lazarus JV, Villota-Rivas M, Ryan P, Buti M, Grau-López L, Cuevas G, Espada JL, Morón W, Palma-Álvarez RF, Feld JJ, Valencia J. Lazarus JV, et al. Commun Med (Lond). 2023 May 12;3(1):66. doi: 10.1038/s43856-023-00292-y. Commun Med (Lond). 2023. PMID: 37173456 Free PMC article.
Elimination of Hepatitis C in Southern Italy: A Model of HCV Screening and Linkage to Care among Hospitalized Patients at Different Hospital Divisions.
Rosato V, Kondili LA, Nevola R, Perillo P, Mastrocinque D, Aghemo A, Claar E. Rosato V, et al. Viruses. 2022 May 19;14(5):1096. doi: 10.3390/v14051096. Viruses. 2022. PMID: 35632837 Free PMC article.
Low prevalence of current and past SARS-CoV-2 infections among visitors and staff members of homelessness services in Amsterdam at the end of the second wave of infections in the Netherlands.
Generaal E, van Santen DKD, Campman SL, Booij MJ, Price D, Buster M, van Dijk C, Boyd A, Bruisten SM, van Dam AP, van der Lubben M, van Duijnhoven YTHP, Prins M. Generaal E, et al. PLoS One. 2023 Jul 25;18(7):e0288610. doi: 10.1371/journal.pone.0288610. eCollection 2023. PLoS One. 2023. PMID: 37490469 Free PMC article.

References

1. WHO . Global Health Sector Strategy on Viral Hepatitis, 2016–2021 Towards Ending Viral Hepatitis. World Health Organization; 2016. https://www.who.int/hepatitis/strategy2016‐2021/ghss‐hep/en/
1. Safreed‐Harmon K, Blach S, Aleman S, et al. The consensus hepatitis C cascade of care: standardized reporting to monitor progress toward elimination. Clin Infect Dis. 2019;69(12):2218‐2227. - PubMed
1. Screening Program a Short Guide Increased Effectiveness Maximize Benefits and Minimize Harm. World Health Organization; 2020. ISBN 978 92 890 5478 2
1. Sagan A, McDaid D, Rajan S, Farrington J, McKee M. Screening. When is it appropriate and how can we get it right? Health systems and policy analysis. Policy Brief 35 Print ISSN 1997–8065 Web ISSN 1997–8073 - PubMed
1. Cox AL, El‐Sayed MH, Kao J‐H, et al. Progress towards elimination goals for viral hepatitis. Nat Rev Gastroenterol Hepatol. 2020;17:533‐542. - PMC - PubMed

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
Medical
- MedlinePlus Health Information

[1] WHO . Global Health Sector Strategy on Viral Hepatitis, 2016–2021 Towards Ending Viral Hepatitis. World Health Organization; 2016. https://www.who.int/hepatitis/strategy2016‐2021/ghss‐hep/en/

[2] WHO . Global Health Sector Strategy on Viral Hepatitis, 2016–2021 Towards Ending Viral Hepatitis. World Health Organization; 2016. https://www.who.int/hepatitis/strategy2016‐2021/ghss‐hep/en/

[3] Safreed‐Harmon K, Blach S, Aleman S, et al. The consensus hepatitis C cascade of care: standardized reporting to monitor progress toward elimination. Clin Infect Dis. 2019;69(12):2218‐2227. - PubMed

[4] Safreed‐Harmon K, Blach S, Aleman S, et al. The consensus hepatitis C cascade of care: standardized reporting to monitor progress toward elimination. Clin Infect Dis. 2019;69(12):2218‐2227. - PubMed

[5] Screening Program a Short Guide Increased Effectiveness Maximize Benefits and Minimize Harm. World Health Organization; 2020. ISBN 978 92 890 5478 2

[6] Screening Program a Short Guide Increased Effectiveness Maximize Benefits and Minimize Harm. World Health Organization; 2020. ISBN 978 92 890 5478 2

[7] Sagan A, McDaid D, Rajan S, Farrington J, McKee M. Screening. When is it appropriate and how can we get it right? Health systems and policy analysis. Policy Brief 35 Print ISSN 1997–8065 Web ISSN 1997–8073 - PubMed

[8] Sagan A, McDaid D, Rajan S, Farrington J, McKee M. Screening. When is it appropriate and how can we get it right? Health systems and policy analysis. Policy Brief 35 Print ISSN 1997–8065 Web ISSN 1997–8073 - PubMed

[9] Cox AL, El‐Sayed MH, Kao J‐H, et al. Progress towards elimination goals for viral hepatitis. Nat Rev Gastroenterol Hepatol. 2020;17:533‐542. - PMC - PubMed

[10] Cox AL, El‐Sayed MH, Kao J‐H, et al. Progress towards elimination goals for viral hepatitis. Nat Rev Gastroenterol Hepatol. 2020;17:533‐542. - PMC - PubMed

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Opportunistic co-screening for HCV and COVID-19-related services: A creative response with a need for thoughtful reflection

Affiliations

Opportunistic co-screening for HCV and COVID-19-related services: A creative response with a need for thoughtful reflection

Authors

Affiliations

Conflict of interest statement

Figures

Comment in

Similar articles

Cited by

References

Publication types

MeSH terms

LinkOut - more resources

Full Text Sources

Medical